These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20632244)

  • 1. Recombinants in thrombosis and hemostasis: from basic research to clinical therapy.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2010 Jul; 36(5):471-6. PubMed ID: 20632244
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.
    Den Uijl I; Mauser-Bunschoten EP; Roosendaal G; Schutgens R; Fischer K
    Haemophilia; 2009 Nov; 15(6):1215-8. PubMed ID: 19686467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Development and Impact of Hemostatic Stewardship Programs.
    Dane KE; Streiff MB; Lindsley J; Montana MP; Shanbhag S
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):887-901. PubMed ID: 31466611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current use of biologicals in thrombosis and haemostasis.
    Ofosu FA; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):805-6. PubMed ID: 18449409
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10).
    Hedner U
    Haemophilia; 2010 Mar; 16(2):372-3. PubMed ID: 20028420
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombosis and haemostasis research: stimulating, hard work and fun.
    Blombäck M
    Thromb Haemost; 2007 Jul; 98(1):8-15. PubMed ID: 17597983
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemostasis and thrombosis research in China.
    Ruan C
    Chin Med J (Engl); 1999 Oct; 112(10):883-6. PubMed ID: 11717969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of estrogen-induced venous thromboembolism.
    Tchaikovski SN; Rosing J
    Thromb Res; 2010 Jul; 126(1):5-11. PubMed ID: 20163835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Oral Anticoagulants in Clinical Practice.
    Connors JM
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):ix-x. PubMed ID: 27637312
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.
    Talbot M
    Semin Thromb Hemost; 1989 Jul; 15(3):293-301. PubMed ID: 2688102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Actual problems of clinical hemostasis].
    Makarov VA
    Klin Med (Mosk); 1990 Jun; 68(6):3-8. PubMed ID: 2214635
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding.
    Hagedorn I; Schmidbauer S; Pleines I; Kleinschnitz C; Kronthaler U; Stoll G; Dickneite G; Nieswandt B
    Circulation; 2010 Apr; 121(13):1510-7. PubMed ID: 20308613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation between the hemostatic process and thrombosis. A clinical problem].
    Ponari O; Dettori AG
    Recenti Prog Med; 1968 Sep; 45(3):259-82. PubMed ID: 4916345
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recombinant protein substances in human medicine].
    Fischer JA
    Dtsch Med Wochenschr; 1989 Feb; 114(5):188-91. PubMed ID: 2644118
    [No Abstract]   [Full Text] [Related]  

  • 16. Face to face with basic and clinical research in Thrombosis and Haemostasis.
    Preissner KT; Lip GY
    Thromb Haemost; 2009 Jan; 101(1):1. PubMed ID: 19132178
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternative and topical approaches to treating the massively bleeding patient.
    Kulkarni R
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):428, 431. PubMed ID: 16163216
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular aspects in clinical hemostasis research at Karolinska Institutet.
    Blombäck M
    Biochem Biophys Res Commun; 2010 May; 396(1):131-4. PubMed ID: 20494125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic use of blood products and their recombinant analogs in patients with disorders of hemostasis].
    Balint B; Taseski J
    Vojnosanit Pregl; 2000; 57(5):69-79. PubMed ID: 11213679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems of the physiological regulation of hemostasis].
    Kudriashov BA
    Usp Sovrem Biol; 1967; 64(2):268-93. PubMed ID: 4923704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.